Boryung KRX:003850KOSPI

보령 · Korean news coverage and regulatory filings, organized.

Articles, 24h28
Articles, 7 days67
DART filings, 7 days4
Articles tracked67since Sep 11

In Q2 2026, Boryung reported revenue of ₩280bn, up 11.2% year on year, and operating profit of ₩23.8bn. Boryung (보령) appeared in 67 Korean news articles and 4 DART filings over the past seven days. Coverage peaked on Sep 11 with 26 articles. The most common catalyst was stakes & m&a (2). It was most often mentioned alongside Hana Pharm and Bioneer.

Boryung quarterly results consolidated, KRW

QuarterRevenueYoYOperating profitNet income
Q2 2026₩280bn+11.2%₩23.8bn₩24.1bn
Q1 2026₩255bn+6.2%₩20.2bn₩41.4bn
Q4 2025 derived₩245bn-4.5%−₩649m₩21.1bn
Q3 2025₩280bn+3.3%₩29.4bn₩34.0bn
Q2 2025₩252bn-1.6%₩25.4bn₩8.9bn
Q1 2025₩241bn+3.0%₩10.9bn₩349m
Q4 2024 derived₩257bn+11.1%₩14.5bn₩13.2bn
Q3 2024₩271bn+30.1%₩19.5bn₩9.4bn

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases.

Boryung top stories 2 weeks, by number of outlets

  1. 1
    충남 재선충병 방제선 확대…보령·서천·청양 ‘특별방제구역’
    5 outlets · 5 articlesFirst report Sep 11 08:48 공뉴스
  2. 2
    보령 '가치가게', 지역상품 판로 확대 성과
    5 outlets · 5 articlesFirst report Sep 14 09:07 국제뉴스
  3. 3
    이삼수 하나제약 사장 차녀 결혼
    4 outlets · 4 articlesFirst report Sep 11 10:06 메디파나뉴스Hana Pharm
  4. 4
  5. 5
    보령, 물적분할 결정…‘보령파마솔루션’ 신설
    3 outlets · 3 articlesFirst report Sep 15 10:48 블로터
  6. 6
    보령, ETC 영업 떼어낸다…‘보령파마솔루션’ 신설
    3 outlets · 3 articlesFirst report Sep 15 11:17 더바이오

Latest Boryung news Korean headlines